GDF15 and cancer: In some disease states, especially in late stage cancer, chronic renal failure and severe congestive heart failure, MIC-1/GDF15 serum levels frequently rise to 10,000 to 20,000 pg per ml and occasionally to much higher levels [5], [14], [15].